+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

From
From
Remicade Biosimilar Global Market Report 2024 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Humira Drug Global Market Report 2024 - Product Thumbnail Image

Humira Drug Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Psoriasis Treatment: Global Strategic Business Report - Product Thumbnail Image

Psoriasis Treatment: Global Strategic Business Report

  • Report
  • March 2024
  • 193 Pages
  • Global
From
Psoriasis Global Market Report 2024 - Product Thumbnail Image

Psoriasis Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
Generalized Pustular Psoriasis (GPP) - Competitive Landscape - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Competitive Landscape

  • Report
  • December 2023
  • 78 Pages
  • Global
From
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more